BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231016
DTEND;VALUE=DATE:20231020
DTSTAMP:20260516T071956
CREATED:20230524T141827Z
LAST-MODIFIED:20230524T141827Z
UID:37236-1697414400-1697759999@www.pharmajournalist.com
SUMMARY:14th World ADC San Diego 2023
DESCRIPTION:The ADC renaissance shows no sign of slowing down with the ground-breaking approval of ELAHERE for platinum resistant ovarian cancer\, Pfizer’s jaw-dropping acquisition of Seagen for $43 billion\, and BMS’ $1 billion+ pact with Tubulis. There has been no better time to reunite the World ADC community and invest in progressing ADCs to front line treatments for patients. \nThe highly anticipated 14th World ADC San Diego (October 16-19\, 2023 | San Diego\, CA) returns as the world’s largest industry-dedicated discussion and networking forum addressing and overcoming the challenges in end-to-end ADC development. \nGain exclusive access to the full event guide to view the full agenda with 120+ industry-leading speakers. \nWhether you’re new to the field or an ADC guru\, there is something for everyone included in this year’s agenda. Some of your must-attend talks per track include: \n\nDiscovery Chemistry: Join Christopher Marvin\, Principal Research Scientist\, AbbVie as he reviews the design and optimization of glucocorticoid receptor modulator payloads for Immunology ADCs\nCellular Biology: Discuss with Robert Lawrence\, Principal Scientist\, Seagen the influence of artificial intelligence on ADC target discovery\nTranslational: Review a best-in-class translational study with Meijuan Li\, Vice President\, Head of Translational Sciences & Biostatistics\, Eisai Oncology\nClinical Lessons: Be the first to hear industry-changing clinical results from ImmunoGen\, Byondis\, Iksuda Therapeutics\, Seagen\, Bliss Bio\, Genentech and Elucidia Oncology\nProcess and Analytical Development: Debate the key considerations for ADC comparability studies in a dedicated roundtable lead by ADC CMC expert\, Julie Beaudet\, CMC Staff Scientist\, Regeneron Pharmaceuticals\nManufacturing and Supply Chain: Explore the manufacturing of novel dolaLock ADCs with supply chain architecture with Engin Ayturk\, Executive Director\, CMC Process Development\, Mersana Therapeutics\n\nAccess to the complete agenda here including a 7-tracked seminar day and 10 industry-beating workshops. \nDon’t miss out on the chance to reunite with the antibody-drug conjugate community while reflecting on the exciting year that ADCs have had\, and building momentum for the future of this innovative field.
URL:https://www.pharmajournalist.com/event/14th-world-adc-san-diego-2023/
LOCATION:Sheraton San Diego Hotel and Marina\, 1380 Harbor Island Dr\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231016
DTEND;VALUE=DATE:20231019
DTSTAMP:20260516T071956
CREATED:20230718T090856Z
LAST-MODIFIED:20230718T090856Z
UID:37484-1697414400-1697673599@www.pharmajournalist.com
SUMMARY:2nd Operationalise: Early Access Programmes Europe Summit
DESCRIPTION:The Early Access Programmes Summit Europe returns for a second year this October\, aiming to help the industry navigate the notoriously complex European regulatory landscape\, and conquer operational hurdles to provide patients in Europe with early access to medicines. \n \nThis meeting provides a forum to address burning questions and share ideas on topics such as European regulatory guidelines\, labelling\, supply\, and best practices around reimbursement\, integrating of pre- and post-trial access programmes and scoping. \nProviding practical\, valuable case studies is this year’s expert speaker lineup including the likes of GlaxoSmithKline\, Roche\, Novartis\, Sanofi\, and many others! Visit our website to download a free copy of the full event guide to explore the jam-packed 3-day agenda and full speaker faculty. \nWhether you’re a veteran at managing early access programmes and are looking to expand your geo\, or a new entrant to the field\, you’ll leave this conference with the practical lessons and essential connections needed to supercharge your European early access programme across 2023 and beyond. \nTo know more visit: https://bit.ly/3K4BpqO
URL:https://www.pharmajournalist.com/event/2nd-operationalise-early-access-programmes-europe-summit/
LOCATION:Hilton Canary Wharf\, South Quay\, Marsh Wall\, London\, E14 9SH\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231016
DTEND;VALUE=DATE:20231019
DTSTAMP:20260516T071956
CREATED:20230831T083951Z
LAST-MODIFIED:20230905T090233Z
UID:37702-1697414400-1697673599@www.pharmajournalist.com
SUMMARY:4th Commercializing Flow Chemistry Summit
DESCRIPTION:Scaling Flow Chemistry for Sustainability\, Safety and Speed to Market  \nWith the growing demand for better flow technology\, the 4th Commercializing Flow Chemistry Summit is your must-attend meeting to deep-dive into transforming your process efficiency\, emerging technology toolbox and economic gains through strategic flow chemistry. \nWith unmissable case studies from the likes of Novartis\, Boehringer Ingelheim\, Sanofi\, AbbVie\, Eli Lilly and Takeda\, this is the definitive forum to benchmark and learn with this forward-thinking community who reunite once more. \nThese industry titans have collaborated to form a comprehensive\, 3-day program covering key topics including: \n\nElevate Sustainability with Industry Leaders: Join forces with Merck\, Eli Lilly and AbbVie to integrate sustainable practices seamlessly into your workflow\, enhancing both environmental responsibility and operational excellence\nUnlock Efficiency through Automation: Discover the power of automation in flow chemistry\, following the footsteps of efficiency leaders like Sanofi\, Takeda\, and Boehringer Ingelheim\, and optimize your processes for peak performance\nMaster Multi-Step Techniques: Gain expert insights from Boehringer Ingelheim on handling multi-step reactions in both flow and batch setups\, fine-tuning your manufacturing processes for maximum efficiency and output\n\nDon’t miss this opportunity to streamline your continuous chemistry research into scaled commercial applications\, and together with 80+ process chemists\, engineers\, and modellers\, go beyond reaction to work up optimization to develop winning processes quicker and expedite your drug development. \nTo know more visit: https://ter.li/jfxs1m
URL:https://www.pharmajournalist.com/event/4th-commercializing-flow-chemistry-summit/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231017
DTEND;VALUE=DATE:20231020
DTSTAMP:20260516T071956
CREATED:20230724T153358Z
LAST-MODIFIED:20230724T153358Z
UID:37509-1697500800-1697759999@www.pharmajournalist.com
SUMMARY:2nd Innate Killer Summit Europe 2023
DESCRIPTION:The 2nd Innate Killer Europe Summit will gather 80+ key European Gamma Delta T\, NK\, iNKT\, neutrophil\, and macrophage developers in October to chase the holy grail of efficacious\, off-the-shelf\, solid tumour immunotherapies through effective and scalable engineering\, engager and combination strategies that promote safe\, potent and persistent innate immune therapies following application. \nDon’t miss this chance to network with innate immune trailblazers from the likes of Sanofi\, Takeda\, Lift Biosciences\, Mink Therapeutics\, Affimed\, Carisma Therapeutics\, Arovella Therapeutics and receive 3-days of some of the best scientific and data driven case studies that will help propel your innate immune therapy into the clinic and beyond. Learn more – https://ter.li/nkcwg3
URL:https://www.pharmajournalist.com/event/2nd-innate-killer-summit-europe-2023/
LOCATION:Crowne Plaza London\, Royal Victoria Dock\, Western Gateway\, London\, E16 1AL\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR